Mitochondrial-Based Chemotherapy

Mitochondrial “Smart Bombs” (Selective Mitochondrial Chemotherapy)
Mitochondria are the powerhouses of the cell, where energy is generated, stored and released. It has long been known that one specific mitochondrial enzyme is restricted to brain cells and is very highly expressed in glioma: monoamine oxidase B (MAO-B). Scientists at the Peak Center have developed a drug that is transformed by MAO-B into a form that is selectively imported into the mitochondria. Once inside the mitochondria, the drug attacks the small mitochondrial genome, damages the mitochondrial DNA, disrupts power generation, and causes the mitochondria to generate harmful free radicals. The result is that glioma cells lose their major power source and the cancer cells die.

Recent research articles
Read article about Successful Treatment of Intracranial Glioblastoma Xenografts with a
Monoamine Oxidase B-Activated Pro-Drug

Read article on Intracranial Glioblastomas: New Hope for an Effective Treatment
Kenneth R. Peak Brain and Pituitary Tumor Treatment & Research Center 
Houston Methodist Hospital - Texas Medical Center
6445 Main Street, Outpatient Center, Floor 24
Houston, TX 77030